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Abstrackr, a semi-automated online screening
program for systematic reviewers
John Rathbone*, Tammy Hoffmann and Paul GlasziouAbstract
Background: Citation screening is time consuming and inefficient. We sought to evaluate the performance of
Abstrackr, a semi-automated online tool for predictive title and abstract screening.
Methods: Four systematic reviews (aHUS, dietary fibre, ECHO, rituximab) were used to evaluate Abstrackr. Citations
from electronic searches of biomedical databases were imported into Abstrackr, and titles and abstracts were
screened and included or excluded according to the entry criteria. This process was continued until Abstrackr
predicted and classified the remaining unscreened citations as relevant or irrelevant. These classification predictions
were checked for accuracy against the original review decisions. Sensitivity analyses were performed to assess the
effects of including case reports in the aHUS dataset whilst screening and the effects of using larger imbalanced
datasets with the ECHO dataset. The performance of Abstrackr was calculated according to the number of relevant
studies missed, the workload saving, the false negative rate, and the precision of the algorithm to correctly predict
relevant studies for inclusion, i.e. further full text inspection.
Results: Of the unscreened citations, Abstrackr’s prediction algorithm correctly identified all relevant citations for
the rituximab and dietary fibre reviews. However, one relevant citation in both the aHUS and ECHO reviews was
incorrectly predicted as not relevant. The workload saving achieved with Abstrackr varied depending on the
complexity and size of the reviews (9 % rituximab, 40 % dietary fibre, 67 % aHUS, and 57 % ECHO). The proportion
of citations predicted as relevant, and therefore, warranting further full text inspection (i.e. the precision of the
prediction) ranged from 16 % (aHUS) to 45 % (rituximab) and was affected by the complexity of the reviews. The
false negative rate ranged from 2.4 to 21.7 %. Sensitivity analysis performed on the aHUS dataset increased the
precision from 16 to 25 % and increased the workload saving by 10 % but increased the number of relevant
studies missed. Sensitivity analysis performed with the larger ECHO dataset increased the workload saving (80 %)
but reduced the precision (6.8 %) and increased the number of missed citations.
Conclusions: Semi-automated title and abstract screening with Abstrackr has the potential to save time and
reduce research waste.Background
Systematic reviews require a comprehensive search and
appraisal of the literature to identify all relevant studies
for inclusion. Typically, this involves a team of reviewers
inspecting thousands of records that are produced from
database searches. The large number of citations re-
trieved is partly due to the inadequate coding of studies
indexed in biomedical databases such as MEDLINE and* Correspondence: jrathbon@bond.edu.au
Centre for Research in Evidence-Based Practice, Bond University, Gold Coast,
Australia
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creativecommons.org/publicdomain/zero/1.0/EMBASE. This produces imprecise search results; some-
times less than 1 % of studies screened are included in a
systematic review [1, 2]. Systematic reviews have also be-
come more time consuming due to the growth in the
volume and scatter of randomised trials [3], additional
reporting steps [4–6], and the incorporation of more
complex methodologies such as network meta-analysis
and the acquisition of clinical study reports [7]. Conse-
quently, many systematic reviews are out of date [8, 9].
With all these challenges, there is a need to adopt tech-
niques from computer science that can semi-automates article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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selection.
Text mining techniques are used to identify relevant in-
formation from text using statistical pattern learning that
recognises patterns in data. Typically, such patterns are
learnt from labelled training data that are then applied to
datasets. A common application of such techniques is
used to separate spam from real emails. Pattern recogni-
tion algorithms aim to provide the most likely matching
of the inputs, taking into account their statistical variation.
They have been applied in a variety of ways in evidence-
based medicine to expedite tasks that would otherwise be
omitted due to the time and cost involved if they were
performed manually. For example, text mining has been
used to assess the frequency of adverse effects of drugs by
analysing patient medical records [10] and to expedite
scoping searches [11]. Text mining has the potential to re-
duce the workload of systematic reviewers by assisting
with the identification of relevant trials during the title
and abstract screening stage of a systematic review.
Abstrackr [12] is a free, open-source [13], citation
screening program, currently at beta testing stage that
uses an algorithm within an active learning framework
to predict the likelihood of citations being relevant. It
uses text unigrams and bigrams within the annotated ab-
stracts for the predictive modelling. Abstrackr biases the
citations so that the most relevant are prioritised for
screening first. Only limited research to date has been
conducted into the strengths and limitations of semi-
automated citation screening [14, 15]. The aim of this
study was to evaluate the performance of the Abstrackr
algorithm. It was chosen for evaluation in preference to
other text mining tools because existing literature indi-
cates that the recall accuracy of Abstrackr is very high
[14–17], and therefore, a promising predictive text min-
ing tool for systematic reviews, where the primary goal
is to identify all relevant studies.
Methods
The trial citations of four systematic reviews [1, 18–20] re-
trieved electronically from biomedical database searches
(MEDLINE, EMBASE, CINAHL, Cochrane CENTRAL)
were used to evaluate Abstrackr. Three systematic reviews
evaluated treatment effectiveness: dietary fibre interventions
for colorectal cancer, rituximab and adjunctive chemother-
apy interventions for non-Hodgkin’s lymphoma, eculizumab
for atypical hemolytic uremic syndrome (aHUS), and one
diagnostic accuracy review of echocardiography (ECHO)
was included. Each systematic review was chosen because of
their different characteristics: for example, the aHUS review
included all study designs except case reports; the interven-
tions in the rituximab review included multiply chemother-
apy interventions rather than a simple drug A versus drug B
comparison; the dataset from the dietary fibre review wasfrom a specialised register which provides a more homoge-
neous and smaller set of citations and therefore presents a
challenge to supervised machine learning algorithms be-
cause they perform better on large datasets; and the ECHO
was chosen because it is a diagnostic accuracy review.
Citations were uploaded to Abstrackr, and titles and ab-
stracts were screened for relevance by one author with rele-
vant studies selected for inclusion and clearly irrelevant
studies excluded. Screening continued until the algorithm’s
stopping criterion indicated that predictions were available
for viewing. This is based upon a simple heuristic requiring
a set number of citations to be screened manually. The
remaining unscreened citations were inspected according to
the probability estimates and hard binary prediction made
by the algorithm and cross-checked against the original re-
view decisions.
The performance of Abstrackr was assessed by calculating
the precision, the false negative rate, the proportion missed,
and the workload saving. The precision is the percentage of
citations predicted relevant by Abstrackr that are subse-
quently deemed relevant by the reviewer for further full text
inspection. The false negative rate is the percentage of cita-
tions that are relevant for further full text inspection but
were predicted to be irrelevant by Abstrackr. The proportion
missed is the number of studies missed by Abstrackr that
were included in the published reviews, out of those studies
predicted to be irrelevant. The workload saving is the pro-
portion of citations predicted irrelevant out of the total
number of citations.
A post hoc sensitivity analysis was performed on the
aHUS dataset because many of the included and ex-
cluded studies were methodologically similar, and there-
fore, excluding near matches might impede the learning
algorithm. For example, case reports were originally ex-
cluded, but case series and RCTs were relevant and in-
cluded. Therefore, by rescreening the aHUS dataset and
also including case reports, we sought to determine if
their inclusion would improve the machine learning pre-
cision by reducing superficially conflicting decisions. A
post hoc sensitivity analysis was also performed on a
substantially larger ECHO dataset to determine if this
would affect the workload saving.
Results
A total for four datasets from existing systematic reviews
(aHUS n = 1415), (dietary fibre n = 517), (ECHO n = 1735)
and (Rituximab n = 1042) were uploaded to Abstrackr and
screened for relevance until the classification algorithm
made predictions.
Atypical haemolytic uremic syndrome dataset (excluding
case reports)
Of 1415 citations, 251 citations were screened (18 %) be-
fore Abstrackr made the predictions, leaving 1164 (82 %)
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374 citations were potentially relevant, and 63 were found
to be relevant, giving a precision of 16.8 % (Fig. 1). The
false negative rate was 10 % (Fig. 2). Of the 790 citations
predicted not relevant, one citation was included in the re-
view, giving a percentage missed of 0.13 % (Fig. 3). As
44 % of citations required screening and checking for rele-
vance, a workload saving of 56 % was achieved (Fig. 4).
Sensitivity analysis of atypical haemolytic uremic syndrome
dataset (including case reports)
The citations were re-screened using the same decisions
to include or exclude citations—with the exception that
case reports were included (even though irrelevant). This
‘homogeneous’ screening method increased the precision
from 16.8 to 25.4 % (Fig. 1) and the false negative rate was
14.3 % (Fig. 2). The number of relevant citations missed,
however, increased to two citations (0.21 %) (Fig. 3). The
workload saving increased from 56 to 67 % (Fig. 3).
Dietary fibre for colorectal cancer dataset
Of 517 citations, 120 citations (23 %) were screened before
Abstrackr made predictions. Abstrackr predicted a further
190 were potentially relevant, and 47 were found to be
relevant, giving a precision of 24.7 % (Fig. 1). The false
negative rate was 14.5 % (Fig. 2). Of the remaining 207 ci-
tations predicted as not relevant by Abstrackr, none were
included in the review—giving a 0 % missed (Fig. 3). Sixty
percent of citations required screening and checking for
relevance, providing a workload saving of 40 % (Fig. 4).
Echocardiography for stroke dataset
Of 1735 citations, 122 (7 %) were screened before Abstrackr
made predictions. Abstrackr predicted that a further 61916.8
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was 4.7 % (Fig. 2). Of the remaining 994 citations predicted
as not relevant by Abstrackr, 993 were correctly excluded;
however, one citation that was included in the review was
missed, giving a percentage missed of 0.10 % (Fig. 3). Forty-
three percent of citations required screening and checking
for relevance, providing a workload saving of 57 % (Fig. 4).Sensitivity analysis of echocardiography for stroke (large
dataset)
The citations were re-screened using a larger dataset of
15,920 citations to determine if precision and workload
saving were affected. Abstrackr made predictions after 495
citations were screened and predicted that 2648 citations
were potentially relevant. Of these, 181 were found to be
relevant for full text inspection, giving a precision of
6.8 %. The false negative rate was 21.7 % (Fig. 2). Of the
remaining 12,777 predicted as not relevant by Abstrackr,
12,775 were correctly predicted as not relevant. However,
two citations that were included in the published review
were missed, giving a percentage missed of 0.02 %. Twenty
percent of citations required screening, providing a work-
load saving of 80 % (Fig. 4).Rituximab for Non-Hodgkin’s lymphoma
Of 1042 citations, 130 citations (12 %) were screened before
Abstrackr made predictions. Abstrackr predicted 817 cita-
tions were potentially relevant, and 372 were found to be
relevant giving a precision of 45.5 % (Fig. 1). The false nega-
tive rate was 2.4 % (Fig. 2). Of the remaining 95 citations
predicted as not relevant by Abstrackr, none were included
in the review, giving a percentage missed of 0 (Fig. 3). As45.5
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vance, there was only a 9 % workload saving (Fig. 4).
Discussion
This study found that Abstrackr has the potential to reli-
ably identify relevant citations and reduce workload
from 9 to 80 %. In two datasets, all relevant citations
were identified, and in the other two datasets, only one
citation was missed. The false negative rate ranged from
2 to 21 %. Overall, precision was good although affected
by the complexity of the review.
In the aHUS dataset, precision was only 16.8 %. This was
due to the complexities of the study inclusion criteria which
included case series as well as other higher quality study de-
signs but not case reports that were excluded during
screening. Because of the lexical similarity between case re-
ports and case series, excluding case reports introduced
greater variance into the machine learning algorithm with
apparent conflicting decisions and consequently reduced
precision. The sensitivity analysis demonstrated that by re-
ducing ‘noise’, the precision could be increased. This0.13
0.10
0.21
0.02
0.00
0.05
0.10
0.15
0.20
0.25
aHUS ECHO
P
er
ce
n
ta
g
e 
m
is
se
d
 (
%
)
1/790*
2/943*
1/994*
2/12,7
Fig. 3 Percentage of studies missed by Abstrackr—but were included in th
(predicted not relevant)problem of ‘noise’ with machine learning is common [21],
and one strategy to increase precision during the data-
training phase is to include close matching records [2], to
ensure the active learning algorithm is not adversely af-
fected, although this requires a degree of expertise to make
decisions contrary to the PICOS (Participants, Interventions,
Comparators, Outcomes and Study design) inclusion cri-
teria. The ECHO sensitivity analysis had the worst precision
(6.8 %) because of the 15,920 citations wherein there was
only about 0.9 % that was relevant. Such imbalanced data-
sets are problematic for supervised machine learning models
like Abstrackr, because the predictions are biased towards
the majority non-relevant class at the expense of the
minority-relevant class [22] and therefore produce many
falsely weighted predictions, i.e. irrelevant citations. Never-
theless, this was off-set by the considerable workload saving.
The false negative rates ranged from 2 to 21.7 % and
represent the percentage of citations that were relevant
for further full text inspection but were predicted to be ir-
relevant by Abstrackr and were therefore ‘missed’. How-
ever, the actual percentage missed were in the range of 00 0
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ation missed by Abstrackr that were included in the re-
view. Therefore, the classification model was almost
completely reliable. The citation missed from the aHUS
and ECHO datasets did not contain an abstract, only a
title and therefore the probability of being predicted rele-
vant was reduced. The aHUS sensitivity analysis missed
two citations, and both contained no abstract. The ECHO
sensitivity analysis missed two citations, one without an
abstract, whilst the other did contain an abstract and it is
unclear why this citation was not detected as relevant.
However, these problems could be minimised by retaining
citations without an abstract for manual inspection.
The complexity of the review PICOS criteria also
affected the workload saving. The workload saving in the
rituximab dataset was low (9 %) due to the rituximab
intervention having multiple adjunctive chemotherapy
treatments which overlapped with non-relevant studies.
Therefore, the good precision and perfect recall accuracy
with the rituximab data were off-set by the minimal work-
load savings suggesting that complex reviews may be less
suited to semi-automated screening. Nevertheless, the
average workload saving across the four datasets was 41 %
and is similar to the findings reported by the developers of
Abstrackr who achieved a 40 % saving in workload from
two datasets [14].
Other data mining algorithms have achieved similar
(40 %) workload savings [16] but recall (identifying rele-
vant records) was lower (90 to 95 %), partly because test-
ing was performed on datasets without a specifically
associated research question. This makes comparisons
with the results of this study difficult. Whilst another text
mining algorithm [17] achieved workload savings ranging
from 8.5 to 62 % with 15 test datasets, which are similar
to our findings with Abstrackr (9 to 80 %), their results
were based on a threshold of a minimum 95 % recall ofrelevant studies, which is too low for systematic reviews.
The developers of Abstrackr reported a recall accuracy of
100 % for relevant studies from three genetics-related data-
sets and 99 % for a fourth dataset, whilst the average speci-
ficity across the four datasets was 87 % [14]. Their results
were based on training the algorithm with balanced data-
sets, which have a similar number of relevant and irrelevant
trials from the original systematic review, and using this
trained algorithm to automatically find studies for the
updates of the genetics-based systematic reviews. This
approach is noteworthy since systematic reviews require
update searches to be performed within 2 years of the first
published version [23], therefore, implementing this strat-
egy, by retaining the original classification model, would ex-
pedite the process of updating systematic reviews.
Strengths and weaknesses of the research
Our findings may be limited by the four datasets used,
and citations from other clinical specialities may yield
different precision and workload saving and miss more
relevant studies for inclusion, especially if the title and
abstract descriptions are inadequate or the study designs
are more complex. Our datasets were from recently pub-
lished systematic reviews that included trials published
mostly from 1995 onwards, and therefore, may contain
better descriptions than older trials that were published
before the CONSORT [24] reporting guidelines were in-
troduced in 1996. Nevertheless, our results for identify-
ing relevant trials are similar to the high recall results of
Wallace (2010 and 2012) and indicate that similar accur-
acy could be achieved when using other datasets of med-
ical citations. Previous text mining studies have mainly
evaluated performance in terms of recall and specificity;
however, our results also analysed the precision of the
predictive model since this measures how precisely the
algorithm selects studies for further full text inspection
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Precision, however, is subjective and influenced by the re-
viewer’s expertise which can affect their screening judge-
ments. The ECHO sensitivity analysis demonstrated that
workload saving with semi-automated screening is more
pronounced with large datasets, and therefore, greater sav-
ings could have resulted had we screened larger reviews.
Nonetheless, the results provide a reasonable estimate of
the algorithm’s typical performance during semi-automated
screening.
This study and others that have evaluated semi-auto-
mated screening with support vector models [14, 15], se-
mantic vector models [16], and complement naïve Bayes
models [17] indicate that considerable workload savings
can be achieved. The ability to identify all relevant citations
with Abstrackr was very high but imperfect. Such accuracy,
however, is acceptable as a stand-alone tool for scoping
searches and non-systematic reviews where not every pub-
lished study needs to be included. It is noteworthy, however,
that human citation screening is imperfect with relevant
studies wrongly excluded [25]. Given that Abstrackr’s in-
accuracy is similar to a human screener, it could be utilised
as the second screener. Abstrackr’s classification prediction
model uses a somewhat arbitrary cutoff point at which the
proportion of citations screened triggers the algorithm pre-
diction. However, this suggests that an adjustable stopping
heuristic could be used, so accuracy could be further im-
proved albeit with the trade-off that more citations are
screened during the training phase.
Future developments with semi-automated screening
would benefit from retaining the original classification
model developed during the original review, so future sys-
tematic review updates may be screened automatically
without the re-input of a reviewer. Abstrackr is not cur-
rently a fully integrated tool, and only the unscreened cita-
tions (the predictions) are exportable with only the title
bibliographic details made available, and further develop-
ments are needed to create a fully integrated tool that sys-
tematic reviewers and information specialists can use.
Text mining algorithms that would enable systematic re-
viewers to exploit the labelling of keywords towards biasing
the predictive classification model to further enhance per-
formance have been proposed [26]. This approach could be
further aided by citation enrichment. For example, key-
words of high relevance such as the PICOS details should
improve the recall accuracy of semi-automated screening
algorithms (and trial searching). Enriching citations is
already being used for the EMBASE project [27] by coding
citations with the type of study design through crowd sour-
cing. Further research and innovations in this underex-
plored area is needed to advance current methods to
eventually enable semi-automated screening to fully replace
manual screening. Current text mining research [28] is fo-
cused on advancing screening retroactively and is restrainedby the limitations of the data available. A more successful
approach may require collaboration with biomedical data-
base providers to ensure that citations are adequately la-
belled prospectively and retrospectively using strategies
such as record linkage techniques, crowd sourcing, or ac-
cess to a central repository, whereby PICOS details can be
inputted and linked to all bibliographic databases.
Conclusions
Semi-automated screening with Abstrackr can potentially
expedite the title and abstract screening phase of a system-
atic review. Although the accuracy is very high, relying
solely on its predictions when used as a stand-alone tool is
not yet possible. Nevertheless, efficiencies could still be
attained by using Abstrackr as the second reviewer thereby
saving time and resources.
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